Sexual dysfunction in females with overactive bladder and their correction with M-cholinolytic spasmex


Cite item

Full Text

Abstract

A 4-month course of spasmex (15 mg three times a day) was conducted in 57 females (age 18-69 years, mean age 48 years) suffering from imperative urination manifesting as pollakiuria, imperative urges and urgent urinary incontinence in combination with sexual disorders. After the treatment the score of urination disorders went down from 21.4 to 12.7. Quality of life score decreased from 4.3 to 1.7. Sexual dysfunction diminished from 3.6 to 0.8 points. Clinical data showed that spasmex has a marked effect on m-cholinoreceptors, is well tolerated, has a moderate spasmolytic effect on the smooth muscles of the lower urinary tract. Moreover, spasmex can be used for correction of female sexual dysfunction caused by overactive bladder.

References

  1. Seftel A. D. Male and female sexual dysfunction. St. Louis: Mosby, Elsiever; 2004. 2.
  2. Standard practice in sexual medicine. Oxford: Blackwell Publihing; 2006.
  3. Basson R., Berman J., Burnett A. et al. Report of the International Consensus Development Conference on female sexual dysfunction: definitions and classifications. J. Urol. (Baltimore) 2000; 163: 888-893.
  4. Dennerstein L., Koochaki P., Barton I., Graziottin A. Hypoactive sexual desire disorder in menopausal women: a survey of western European women. J. Sex. Med. 2006; 3 (Suppl. 2): 212-222.
  5. Vats V., Morant S., Chapple C., Kelleher C. Increased sexual dysfunction in women with LUTS including OAB in a UK general practice setting: analyses from the thin database. Eur. Urol. Suppl. 2008; 7 (2): 290.
  6. Salonia A., Zanni G., Nappi R. E. et al. Sexual dysfunction is common in women with lower urinary tract symptoms and urinary incontinence: results of a cross-sectional study. Europ. Urol. 2004; 45 (5): 642-648.
  7. Osborn M., Hawton K., Gath D. Sexual dysfunction among middle-aged women in the community. Br. Med. J. 1988; 296 (6627): 959-962.
  8. Kelleher С. J., Cardozo L. D., Toozs-Hobson P. M. Quality of life and urinary incontinence. Curr. Opin. Obstet. Gynecol. 1995; 7 (Suppl. 5): 404-408.
  9. Patrick D. L., Martin M. L., Bushnell D. M. et al. Quality of life of women with urinary incontinence: further Development of the incontinence quality of instrument (I-QOL). Urology 1999; 53 (Suppl. 1): 71-76.
  10. Steers W. D. Overactive bladder (OAB): What we thought we knew and what we know today. Eur. Urol. Suppl. 2002; 1 (4): 3-10.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies